Abstract: Apparatus and methods for sounding reference signal (SRS) switching are provided. In certain embodiments, a controller internal to the power amplifier module initiates a sequence of instructions, in response to a single command from UE. The instructions cause a reduction in RF signal amplitude at the power amplifier output and then cause the antenna switch to actuate. Thus ensuring a single command transition and preventing over-power on the power amplifier and antenna switch. The teachings herein can be used to facilitate reduction in gap times between transitions on different antennas and avoid the use of a blank symbol before and after each SRS symbol.

Abstract: Compounds of formula (I): characteristically activators of receptors of PPAR type, are well suited for treating cutaneous disorders/afflictions, notably rosacea, intrinsic (or chronological) aging, pigmentation disorders, seborrhoeic function disorders, barrier function disorders and more particularly epidermal lipid secretion disorders, wound healing disorders, corticosteroid-induced cutaneous atrophies, or ulcers, immune system disorders, cardiovascular system conditions, and/or lipid metabolism disorders.

Abstract: A novel combination of one or more ligands with VDR receptor selective activity and one or more retinoids selective for RAR&ggr; receptors as opposed to RAR&agr; receptors is described, as well as the use thereof in cosmetic and skin-care applications for treating disorders related to a hyperproliferation of cells, in particular skin cells, such as psoriasis.

Abstract: The invention concerns a seat, in particular for a motor vehicle, comprising a seat back, a cushion, a pivoting handle mounted on one of the lateral sides of the seat back and adapted to cause the seat back to tilt onto the cushion from a raised position, a rotary plate fixed under the cushion, and a pivoting lever affixed to the rotary plate and adapted to cause the cushion to rotate on itself with the seat back in the raised position. According to the invention, the seat comprises means for pivoting the pivoting lever immediately after the handle has pivoted so as to cause the cushion to rotate about the rotation axis of the rotary plate immediately after the back has been tilted on the cushion.

Abstract: Novel pharmaceutically/cosmetically-active (poly)thiaalkynoic compounds have the structural formula (I): R1—Y—CH2—C≡C—CH2—S—CH2—R2  (I) and are useful for the treatment of a wide variety of disease states, whether human or veterinary, for example inflammation disorders, as well as for the treatment of mammalian skin and hair conditions/disorders.

Abstract: Compounds of formula (I): 1

Abstract: The invention concerns a seat, in particular for a motor vehicle, comprising a seat back, a cushion, a pivoting handle mounted on one of the lateral sides of the seat back and adapted to cause the seat back to tilt onto the cushion from a raised position, a rotary plate fixed under the cushion, and a pivoting lever affixed to the rotary plate and adapted to cause the cushion to rotate on itself with the seat back in the raised position. According to the invention, the seat comprises means for pivoting the pivoting lever immediately after the handle has pivoted so as to cause the cushion to rotate about the rotation axis of the rotary plate immediately after the back has been tilted on the cushion.

Abstract: The invention concerns the use of at least one activator of receptors of the PPAR-&ggr; type for preparing a pharmaceutical composition for treating skin disorders related to an anomaly of the differentiation of epidermic cells.

Abstract: Compounds of formula (I): 1

Abstract: Compounds of formula (I): 1

Abstract: The retinoids, in particular the anti-AP-1 retinoids, effectively inhibit the expression of VEGF, and thus are useful for the therapeutic treatment of disease states manifesting an overexpression of VEGF.

Abstract: Pharmaceutical/dermatological compositions comprising (a) at least one first ligand displaying selective activity for the RXR receptors and (b) at least one second ligand displaying selective activity for the RAR-.alpha. receptor, are useful for modulating the proliferation and/or differentiation of HL-60 type cells, in particular for the systemic treatment of acute promyelocytic leukemia.

Abstract: The subject invention relates to a method of diagnosing epidermis differentiation disorders in a patient by obtaining an epidermis sample from the patient, adding to the sample, antibodies that specifically bind to an antigen of the stratum corneum, the said antigen being specifically recognized by BC 21 monoclonal antibody and detecting the presence or absence of the antibodies that are specifically bound to the epidermis sample.

Abstract: The subject invention relates to monoclonal antibodies which react with antigenic determinants which are present of the stratus corneum of human epidermis. Furthermore, the invention also relates to methods of using such monoclonal antibodies in immunoassays. One monoclonal antibody of the present invention which is particularly useful is BC 21.